You can buy or sell PSTI and other stocks, options, ETFs, and crypto commission-free!
Pluristem Therapeutics, Inc. Common Stock, also called Pluristem Therapeutics, is a biotechnology company, which engages in the provision of cell therapy development. Read More It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
52 Week High
52 Week Low
Expected Sep 30, After Hours